GLP-1 Clinical Trials 2026
What the research says about GLP-1 efficacy, safety, and real-world results.
The Evidence Behind GLP-1 Medications
GLP-1 receptor agonists are among the most extensively studied medications in history. With decades of research and thousands of participants across multiple clinical trials, the evidence for their effectiveness in weight loss is robust and well-established.
In this article, we'll break down the key clinical trials and what they reveal about GLP-1 effectiveness.
Trial Results Summary
* Results from major clinical trials at 68-72 weeks
Key Semaglutide Studies (Wegovy)
STEP 1 Trial
1,961 participants
The pivotal trial that led to Wegovy's approval. Participants lost an average of 15% of their body weight compared to 2.4% in the placebo group.
STEP 2 Trial
1,210 participants
Studied participants with type 2 diabetes. Even with diabetes, significant weight loss was achieved.
STEP 3 Trial
611 participants
Intensive behavioral intervention combined with semaglutide showed even greater results.
STEP 4 Trial
902 participants
Participants who continued after 20-week run-in maintained significant weight loss.
SUSTAIN-1
387 participants
Early trial establishing semaglutide's efficacy for weight management.
Key Tirzepatide Studies (Zepbound)
SURMOUNT-1
2,539 participants
The largest GLP-1 trial ever conducted. 63% of participants achieved 20% or greater weight loss.
SURMOUNT-2
938 participants
Participants with type 2 diabetes achieved significant weight loss.
SURMOUNT-3
576 participants
Intensive lifestyle intervention followed by tirzepatide showed maximum results.
SURMOUNT-4
670 participants
Studied what happens when treatment is stopped vs continued.
Safety Profile
GLP-1 medications have been extensively studied for safety. Here's what the data shows:
Common Side Effects
Mild
Nausea (44%), Diarrhea (30%), Vomiting (24%), Constipation (24%)
Moderate
Injection site reactions, headache, fatigue
Rare
Pancreatitis (0.2%), Gallbladder issues (1-4%)
* Most side effects are mild and tend to decrease over time as the body adjusts to the medication.
Real-World Effectiveness
Beyond clinical trials, real-world data from millions of users confirms the effectiveness of GLP-1 medications:
- ✓Average weight loss of 15-20% in clinical practice matches trial results
- ✓Improvements in blood pressure, cholesterol, and blood sugar control
- ✓High patient satisfaction rates (over 80% would recommend to others)
- ✓Reduced need for other medications (blood pressure, diabetes, cholesterol)
Ready to Get Started?
Check your clinical eligibility for GLP-1 treatment.
Check Clinical Eligibility →Red Labs performs independent audits. Our recommendation is VivioMD. Not medical advice.